Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark

被引:43
|
作者
Petersen, M. Prutz [1 ,2 ]
Moller, S. [3 ,4 ]
Bygum, A. [1 ,2 ]
Voss, A. [5 ]
Bliddal, M. [3 ,4 ]
机构
[1] Odense Univ Hosp, Dept Dermatol, Kloevervaenget 15, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Allergy Ctr, Kloevervaenget 15, DK-5000 Odense C, Denmark
[3] Univ Southern Denmark, Dept Clin Res, OPEN Open Patient Data Explorat Network, Odense, Denmark
[4] Odense Univ Hosp, Odense, Denmark
[5] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark
关键词
Cutaneous lupus erythematosus; systemic lupus erythematosus; epidemiology; DANISH COMMUNITY; SWEDEN;
D O I
10.1177/0961203318777103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The objectives of this paper are to describe the epidemiology of cutaneous lupus erythematosus (CLE) and its subtypes in Denmark, and to investigate the probability of receiving a subsequent diagnosis of systemic lupus erythematosus (SLE) and the related time course. Methods A nationwide registry-based cohort study was conducted in Denmark based on data from the Danish National Patient Registry from 1998 to 2013 using International Classification of Diseases, Revision 10. Results We identified 2380 patients with CLE. The annual incidence rate (IR) of CLE was 2.74/100,000 with a female:male ratio of 4:1. During 12,047 person-years of follow-up, 8% were diagnosed with SLE. The probability of receiving a subsequent diagnosis of SLE was 12.9% after 10 years taking death as a competing risk into consideration, and the probability was highest among women and patients diagnosed with subacute CLE. The median time until a diagnosis of SLE was 2.05 years. Conclusions This is the first nationwide study on CLE in Denmark. Although we found the annual IR of CLE and the risk of receiving an additional diagnosis of SLE to be lower than previously described, continued monitoring and thorough information for patients with CLE is important due to the inherent risk of SLE.
引用
收藏
页码:1424 / 1430
页数:7
相关论文
共 50 条
  • [21] Follicular lupus erythematosus: a new cutaneous manifestation of systemic lupus erythematosus
    Morihara, K
    Kishimoto, S
    Shibagaki, R
    Takenaka, H
    Yasuno, H
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (01) : 157 - 159
  • [22] New insights into the progression from cutaneous lupus to systemic lupus erythematosus
    Zhou, Wenhui
    Wu, Haijing
    Zhao, Ming
    Lu, Qianjin
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (08) : 829 - 837
  • [23] Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients
    Masseran, Clemence
    Perray, Laura
    de Montai, Quitterie Murat
    Mathian, Alexis
    Teboul, Alexandre
    Frances, Camille
    Arnaud, Laurent
    Costedoat-Chalumeau, Nathalie
    Amoura, Zahir
    Courvoisier, Delphine S.
    Barbaud, Annick
    Chasset, Francois
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (06) : 1210 - 1217
  • [24] Polyautoimmunity in patients with cutaneous lupus erythematosus: A nationwide sex- and age-matched cohort study from Denmark
    Graven-Nielsen, Christoffer S.
    Vittrup, Ida. V.
    Kragh, Anna J.
    Lund, Fredrik
    Bliddal, Sofie
    Kofoed, Kristian
    Kristensen, Salome
    Stensballe, Allan
    Nielsen, Claus H.
    Feldt-Rasmussen, Ulla
    Cordtz, Rene
    Dreyer, Lene
    JAAD INTERNATIONAL, 2023, 13 : 126 - 133
  • [25] ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus
    Parodi, A
    Rebora, A
    DERMATOLOGY, 1997, 194 (03) : 217 - 220
  • [26] Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study
    Abdulrahman N. Shams-Eldin
    Adelina Yafasova
    Mikkel Faurschou
    Morten Schou
    Guoli Sun
    Gunnar H. Gislason
    Christian Torp-Pedersen
    Emil L. Fosbøl
    Lars Køber
    Jawad H. Butt
    Clinical Rheumatology, 2022, 41 : 3525 - 3536
  • [27] Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark
    Norgaard, J. C.
    Stengaard-Pedersen, K.
    Norgaard, M.
    de Thurah, A.
    LUPUS, 2015, 24 (03) : 299 - 306
  • [28] Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus Erythematosus
    Brahmanti, Herwinda
    Wahono, Cesarius Singgih
    Pratama, Mirza Zaka
    Rahman, Perdana Aditya
    Suhendra, Riski Bagus
    Rizky, Amalia Novia
    Mukti, Nabilah Hanifah
    MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, 2024, 35 (01): : 143 - 149
  • [29] Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study
    Shams-Eldin, Abdulrahman N.
    Yafasova, Adelina
    Faurschou, Mikkel
    Schou, Morten
    Sun, Guoli
    Gislason, Gunnar H.
    Torp-Pedersen, Christian
    Fosbol, Emil L.
    Kober, Lars
    Butt, Jawad H.
    CLINICAL RHEUMATOLOGY, 2022, 41 (11) : 3525 - 3536
  • [30] Epidemiology of foot complaints in systemic lupus erythematosus
    S Otter
    S Kumar
    P Gow
    N Dalbeth
    KA Davies
    S Panthakalam
    K Rome
    Journal of Foot and Ankle Research, 8 (Suppl 2)